JPMorgan Chase & Co’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $740K | Sell |
|
|||||
|
2025
Q1 | $1.1M | Buy |
|
|||||
|
2024
Q4 | $765K | Buy |
|
|||||
|
2024
Q3 | $399K | Buy |
|
|||||
|
2024
Q2 | $332K | Sell |
|
|||||
|
2024
Q1 | $507K | Sell |
|
|||||
|
2023
Q4 | $282K | Buy |
|
|||||
|
2023
Q3 | $177K | Sell |
|
|||||
|
2023
Q2 | $262K | Sell |
|
|||||
|
2023
Q1 | $979K | Buy |
|
|||||
|
2022
Q4 | $160K | Sell |
|
|||||
|
2022
Q3 | $491K | Buy |
|
|||||
|
2022
Q2 | $494K | Sell |
|
|||||
|
2022
Q1 | $503K | Buy |
|
|||||
|
2021
Q4 | $610K | Buy |
|
|||||
|
2021
Q3 | $1.02M | Buy |
|
|||||
|
2021
Q2 | $1.2M | Buy |
|
|||||
|
2021
Q1 | $965K | Buy |
|
|||||
|
2020
Q4 | $1.49M | Buy |
|
|||||
|
2020
Q3 | $1.2M | Sell |
|
|||||
|
2020
Q2 | $1.36M | Sell |
|
|||||
|
2020
Q1 | $847K | Sell |
|
|||||
|
2019
Q4 | $1.07M | Sell |
|
|||||
|
2019
Q3 | $917K | Buy |
|
|||||
|
2019
Q2 | $739K | Buy |
|
|||||
|
2019
Q1 | $788K | Sell |
|
|||||
|
2018
Q4 | $637K | Buy |
|
|||||
|
2018
Q3 | $798K | Buy |
|